Advertisement
ANI Pharma Guides FY23 Adj. EPS Below Estimates, But Revenues Above - Update
(RTTNews) - While reporting financial results for the fourth quarter on Thursday, biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) initiates adjusted earnings and net revenue guidance for the full-year 2023.
For fiscal 2023, the company now projects adjusted earnings in a range of $2.09 to $2.59 per share on net revenues between $360 million and $385 million, with purified cortrophin gel revenue at $80 million to $90 million.
On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.62 per share on revenues of $352.49 million for the year. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
ANI Pharma Launches Kionex Suspension For Oral Or Rectal Use
Biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) announced Monday the launch of Kionex (Sodium Polystyrene Sulfonate Suspension USP) for Oral or Rectal use.
RTTNews
|
366 дней спустя
ANI Pharma Says FDA Approves Methsuximide Capsules, Alendronate Sodium Oral Solution
ANI Pharmaceuticals, Inc. (ANIP) announced Monday that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Applications (ANDAs) for Methsuximide Capsules USP, 300 mg and Alendronate Sodium Oral Solution 70 mg (base)/75 mL.
RTTNews
|
737 дней спустя
ANI Pharmaceuticals Says FDA Oks ANDA For Clorazepate Dipotassium Tablets
ANI Pharmaceuticals, Inc. (ANIP) announced Wednesday that it has received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Clorazepate Dipotassium Tablets.
RTTNews
|
1064 дней спустя
Bay Street Seen Opening On Mixed Note
Canadian shares are likely to open on a mixed note Wednesday morning. Weak European stocks, concerns about U.S. debt, impasse over peace talks and a lack of progress in trade negotiations may weigh on sentiment.
Firm bullion and crude oil prices could trigger buying in resources sectors and limit market's downside.
RTTNews
|
2ч 55мин назад
UK Inflation Strongest Since Early 2024 On Household Bills, Employer Tax
UK consumer price inflation accelerated sharply to the highest level in more than a year in April due to higher domestic bills and the hike in employers' taxes, official data revealed on Wednesday. The consumer price index rose by a bigger-than-expected 3.5 percent year-on-year in April, which was faster than the 2.6 percent increase in March, the Office for National Statistics reported.
RTTNews
|
3ч 45мин назад
FTSE 100 Down Marginally As Investors Focus On Inflation Data, Earnings
U.K. stocks are marginally down on Wednesday amid concerns over an impasse in Russia-Ukraine peace talks, a lack of progress in trade negotiations, and data showing an acceleration in British consumer price inflation in the month of April.
Investors are also reacting to some corporate earnings announcements.
RTTNews
|
3ч 52мин назад
CAC 40 Moderately Lower In Cautious Trade
French stocks are under a bit of pressure on Wednesday amid uncertainty about Ukraine-Russia peace talks, and a lack of positive progress on the trade front. The recent downgrade of U.S. sovereign credit rating by Moody's weigh as well on investor sentiment.
RTTNews
|
4ч 25мин назад
Sensex, Nifty Snap Three-day Losing Streak
Indian shares eked out modest gains on Wednesday, after having suffered heavy losses in the previous session amid rising geopolitical tensions, growing concerns over U.S. debt and a spike in Covid-19 cases in Southeast Asia.
RTTNews
|
4ч 32мин назад
